Basic fibroblast growth factor controls migration in human mesenchymal stem cells

Stem Cells

Volumn 24, Issue 7, 2006, Pages 1750-1758

  Schmidt, Annette ^a   Ladage, Dennis ^b   Schinköthe, Timo ^b   Klausmann, Ursula ^a   Ulrichs, Christoph ^a   Klinz, Franz Josef ^b   Brixius, Klara ^b   Arnhold, Stefan ^b   Desai, Biren ^b   Mehlhorn, Uwe ^b   Schwinger, Robert H G ^b   Staib, Peter ^b   Addicks, Klaus ^b   Bloch, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Basic fibroblast growth factor; Growth factors; Human mesenchymal stem cells; Migration

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ERYTHROPOIETIN; HEPARIN; INTERLEUKIN 6; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1BETA; VASCULOTROPIN; ACTIN; FIBROBLAST GROWTH FACTOR 2; ONCOPROTEIN; VIMENTIN;

ACTIN FILAMENT; ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; WOUND HEALING; AGED; CELL CULTURE; CELL MOTION; CELL POLARITY; DRUG EFFECT; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TISSUE DISTRIBUTION;

ACTINS; AGED; AGED, 80 AND OVER; CELL MOVEMENT; CELL POLARITY; CELLS, CULTURED; CYTOSKELETON; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HUMANS; MESENCHYMAL STEM CELLS; MIDDLE AGED; ONCOGENE PROTEIN V-AKT; TISSUE DISTRIBUTION; VIMENTIN; WOUND HEALING;

EID: 33749071053     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0191     Document Type: Article

References (52)

1. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
2. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-1166.
3. Meinel L, Karageorgiou V, Fajardo R et al. Bone tissue engineering using human mesenchymal stem cells: Effects of scaffold material and medium flow. Ann Biomed Eng 2004;32:112-122.
4. Meinel L, Karageorgiou V, Hofmann S et al. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A 2004;71:25-34.
5. Li WJ, Tuli R, Okafor C et al. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2004;26:599-609.
6. Koike N, Fukumura D, Gralla O et al. Tissue engineering: Creation of long-lasting blood vessels. Nature 2004;428:138-139.
7. Orlic D, Kajstura J, Chimenti S et al. Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 2003;7(suppl 3):86-88.
8. Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation 2003;107:929-934.
9. Wang JS, Shum-Tim D, Chedrawy E et al. The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 2001;122:699-705.
10. Tomita S, Mickle DA, Weisel RD et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002;123:1132-1140.
11. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science 2002;298:2188-2190.
12. Leferovich JM, Bedelbaeva K, Samulewicz S et al. Heart regeneration in adult MRL mice. Proc Natl Acad Sci U S A 2001;98:9830-9835.
13. Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001;98:10344-10349.
14. Jackson KA, Majka SM, Wang H et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-1402.
15. Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918.
16. Hill JM, Dick AJ, Raman VK et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003;108:1009-1014.
17. Kraitchman DL, Heldman AW, Atalar E et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003;107:2290-2293.
18. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004;95:9-20.
19. Ji JF, He BP, Dheen ST et al. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. STEM CELLS 2004;22:415-427.
20. Moore MA, Hattori K, Heissig B et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci 2001;938:36-45.
21. Heil M, Mitnacht-Krauss R, Issbrucker K et al. An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilization of precursor cells. Angiogenesis 2003;6:201-211.
22. Hughes GC, Biswas SS, Yin B et al. Therapeutic angiogenesis in chronically ischemic porcine myocardium: Comparative effects of bFGF and VEGF. Ann Thorac Surg 2004;77:812-818.
23. Lauffenburger DA, Horwitz AF. Cell migration: A physically integrated molecular process. Cell 1996;84:359-369.
24. Klinz FJ, Schmidt A, Schinkothe T et al. Phospho-eNOS Ser-114 in human mesenchymal stem cells: Constitutive phosphorylation, nuclear localization and upregulation during mitosis. Eur J Cell Biol 2005;84:809-818.
25. Shur I, Reish O, Ezra E et al. Analysis of mesenchymal cells derived from an chondrodysplasia punctuate patient and donors. J Cell Biochem 2004;93:112-119.
26. Faber-Elman A, Solomon A, Abraham JA et al. Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: In vitro simulation. J Clin Invest 1996;97:162-171.
27. ImageJ Version 1.33. National Institutes of Health, USA. Available at http://rsb.info.nih.gov/ij/download.html. 2004.
28. Schmidt A, Wenzel D, Ferring I et al. Influence of endostatin on embryonic vasculo- and angiogenesis. Dev Dyn 2004;230:468-480.
29. Mulloy B, Forster MJ. Conformation and dynamics of heparin and heparan sulfate. Glycobiology 2000;10:1147-1156.
30. Tumova S, Woods A, Couchman JR. Heparan sulfate proteoglycans on the cell surface: Versatile coordinators of cellular functions. Int J Biochem Cell Biol 2000;32:269-288.
31. Faham S, Hileman RE, Fromm JR et al. Heparin structure and interactions with basic fibroblast growth factor. Science 1996;271:1116-1120.
32. Vlahos CJ, Matter WF, Hui KY et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994;269:5241-5248.
33. Datta SR, Brunet A, Greenberg ME. Cellular survival: A play in three Akts. Genes Dev 1999;13:2905-2927.
34. Givol D, Yayon A. Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity. FASEB J 1992;6:3362-3369.
35. Miao HQ, Ishai-Michaeli R, Atzmon R et al. Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation. J Biol Chem 1996;271:4879-4886.
36. Newman DR, Li CM, Simmons R et al. Heparin affects signaling pathways stimulated by fibroblast growth factor-1 and -2 in type II cells. Am J Physiol Lung Cell Mol Physiol 2004;287:L191-L200.
37. Fannon M, Forsten KE, Nugent MA. Potentiation and inhibition of bFGF binding by heparin: A model for regulation of cellular response. Biochemistry 2000;39:1434-1445.
38. Ornitz DM, Xu J, Colvin JS et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996;271:15292-15297.
39. Shaoul E, Reich-Slotky R, Berman B et al. Fibroblast growth factor receptors display both common and distinct signaling pathways. Oncogene 1995;10:1553-1561.
40. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992;59:115-165.
41. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-447.
42. Landgren E, Klint P, Yokote K et al. Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding. Oncogene 1998;17:283-291.
43. Stavri GT, Zachary IC, Baskerville PA et al. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 1995;92:11-14.
44. Kuwabara K, Ogawa S, Matsumoto M et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A 1995;92:4606-4610.
45. Klint P, Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front Biosci 1999;4:D165-D177.
46. Wang JK, Gao G, Goldfarb M. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol Cell Biol 1994;14:181-188.
47. Klint P, Kanda S, Kloog Y et al. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Oncogene 1999;18:3354-3364.
48. Kuo WL, Chung KC, Rosner MR. Differentiation of central nervous system neuronal cells by fibroblast-derived growth factor requires at least two signaling pathways: Roles for Ras and Src. Mol Cell Biol 1997;17:4633-4643.
49. Sakakibara Y, Tambara K, Sakaguchi G et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg 2003;24:105-111.
50. Yanagisawa-Miwa A, Uchida Y, Nakamura F et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-1403.
51. Laham RJ, Sellke FW, Edelman ER et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999;100:1865-1871.
52. Unger EF, Banai S, Shou M et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994;266:H1588-H1595.